期刊文献+

HPLC测定新型噁唑烷酮类药物YC-12的含量及有关物质 被引量:1

Determination of the content of new oxazolidinone derivatives YC-12 and its related substances by HPLC
暂未订购
导出
摘要 目的噁唑烷酮类抗菌药是一类新型化学令合成抗菌药,具有抑制多重耐药革兰阳性菌的作用,本文建立高效液相色谱法测定新型噁唑烷酮类药物YC-12的含量及检查有关物质。方法采用Diamonsil C18柱(250mm×4.6mm,5μm),磷酸盐缓冲溶液(1000mL水+2g磷酸二氢钾+3.5mL三乙胺+3mL磷酸)-乙腈-甲醇(42:30:28)为流动相;流速为1mL/min:检测波长254nm,柱温为25℃。结果主峰能与相邻杂质峰达基线分离,YC-12的浓度在10~200μg/mL范围内线性关系良好,相关系数为0.9994,最低检测限为0.5ng。结论该法简便、准确,灵敏度高,专属性强,可以用于YC-12的含量及有关物质的测定。 Objective Totally-synthetic oxazolidinones are a new class of antibacterial agents for the treatment of the infections caused by gram-positive bacteria including the multidrug-resistant pathogens. To develop an HPLC method for determination of new oxazolidinone derivatives YC-12 and its related substances. Methods The chromatographic separation of YC-12 was performed on a Diamonsil C18 column with a mobile phase consisting of phosphate buffered solution(1000mL H2O with 2.0g potassium dihydrogen phosphate, 3.5mL triethylamine and 3mL Phosphoric Acid)- acetonitrile-methanol(42:30:28, v/v/v) with a flow rate of 1.0mL/min. The detection was monitored at 254 nm, and the column temperature was maintained at 25℃. Results YC-12 was completely separated from its related substances. The calibration curve of YC-12 was linear in the range of 10-200μg/mL with the correlation coefficient of 0.9994. The limit of detection was 0.5ng. Conclusion The method is simple, rapid, sensitive and specific, and can be used for determination of YC-12 and its related substances.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2011年第6期445-448,共4页 Chinese Journal of Antibiotics
基金 国家高技术研究发展计划(863计划)重大科技专项。基金号2004AA2Z3201
关键词 噁唑烷酮 YC-12 HPLC 含量测定 有关物质 New oxazolidinone derivatives YC-12 HPLC Determination Related Substances
  • 相关文献

参考文献5

二级参考文献38

  • 1王震宇,朱雄,王尔华.卢帕他定中间体5-甲基吡啶-3-羧酸的合成工艺改进[J].药学进展,2005,29(1):31-33. 被引量:3
  • 2霍保方,肇丽梅,邱枫,孙亚欣,徐英宏.HPLC测定血浆中的头孢克肟及其人体药动学的研究[J].华西药学杂志,2005,20(4):312-313. 被引量:10
  • 3张万金,罗艳,张燕梅.卢帕他定的合成[J].中国医药工业杂志,2006,37(7):433-435. 被引量:6
  • 4胡敏,胡昌勤.LC-MS法分析头孢硫脒降解产物[J].药学学报,2006,41(10):1015-1019. 被引量:27
  • 5Izquierdo I, Merlos M, Garcia - Rafanell J. Rupatadine : a new selective histamine H1 receptor and platelet -activating factor(PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis. Drugs Today (Barc) ,2003,39 ( 6 ) :451
  • 6Solans A, Izquierdo I, Donado E, et al. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady - state levels : a randomized, open - label, two - way, crossover, Phase Ⅰ study. Clin Ther,2008,30 (9) : 1639
  • 7Natesan S,Deekonda S,Manoj KK,et al.Synthesis of conformationally constrained analogues of linezolid:structure-activity relationship(SAR)studies on selected novel tricyclic oxazolidinones[J].J Med Chem,2002,45(18):3953-3962.
  • 8Steven JB,Douglas KH,Michael RB,et al.Synthesis and antibacterial activity of U-100592 and U-100766,two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infection[J].J Med Chem,1996,39(3):673-67
  • 9Michael RB,Gary JC,Lester AD,et al.Identification of phenylisoxazolines as novel and viable antibacterial agents active against gram-positive pathogens[J].J Med Chem,2003,46(2):284-302.
  • 10Johannes SB.Some substituted tetrahydroisoquinoline hydrochlorides[J].J Am Chem Soc,1934,56(8):1769-1771.

共引文献17

同被引文献5

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部